Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_assertion type Assertion NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_head.
- NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_assertion description "[The expression of a group of proteins, haptoglobin (Hp), alpha-1-antitrypsin, apolipoprotein A-IV, serum paraoxonase and Zn-alpha-glycoprotein were increased and the proteins, clusterin precursor, alpha-2-macroglobulin, serum amyloid protein precursor, sex hormone-binding globulin, serotransferrin and complement C4 were decreased in patients with extensive chronic GVHD (cGVHD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_provenance.
- NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_assertion evidence source_evidence_literature NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_provenance.
- NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_assertion SIO_000772 19379511 NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_provenance.
- NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_assertion wasDerivedFrom befree-20140225 NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_provenance.
- NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_assertion wasGeneratedBy ECO_0000203 NP671233.RA1u7z6auxUcQ2QOTwA10GYNGiyG6d52JCtAQhHBhyTf4130_provenance.